This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Campus
  1. Article
  2. Source: Campus Sanofi
  3. 1 Feb 2024

Adopting big data & artificial intelligence to advance diagnosis for rare diseases

Author: Sanofi

Editorial Team

Sanofi is working to harness this modern technology to strengthen understanding and diagnostic outcomes for those living with a rare disease.


Highlight reel

Listen to Lucy McKay, CEO of Medics4Rare and Silvia Cerolini, Head of Innovation Specialty Care, Sanofi discuss the benefits of artificial intelligence (AI) and big data in the field of rare disease: “Tools like AI can search for cases, […], who might have a rare condition, in a way that without academic and personal experience, a doctor’s not going to be able to do for all of these rare conditions.”
Lucy McKay

This recording is organised and funded by Sanofi.

In conversation with Lucy McKay, CEO of Medics4RareDiseases & Silvia Cerolini, Head of Innovation Specialty Care, Sanofi

To explore the diagnostic odyssey further, Dr Lucy McKay and Silvia Cerolini take a deeper dive into this potentially life-changing technology, including the benefits and possible challenges that come with the use of big data and AI in the rare disease arena.

This recording is organised and funded by Sanofi.

Ways to apply digital and technological solutions to benefit people with rare diseases

Medical scientific staff

Find out more about the transformative potential that collaboration and new technology hold in the field of rare diseases.

5 minute read

MAT-XU-2305393 (v1.0) Date of preparation: February 2024